Lexington, MA, United States of America

Erik Held

This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Translate Bio, Inc.. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Erik Held. Retrieved from https://idiyas.com/inventor/erik-held

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 2 

% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2024

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Erik Held - Innovator in RNA Purification

Introduction

Erik Held is a notable inventor based in Lexington, MA (US). He has made significant contributions to the field of biotechnology, particularly in the purification of messenger RNA (mRNA). With a total of 2 patents to his name, Erik's work is pivotal for therapeutic applications.

Latest Patents

Erik's latest patents focus on methods for the purification of messenger RNA. The present invention provides, among other things, methods for purifying mRNA based on normal flow filtration for therapeutic use. This innovative approach enhances the efficiency and effectiveness of mRNA purification, which is crucial for various medical applications.

Career Highlights

Erik Held is currently associated with Translate Bio, Inc., a company dedicated to developing transformative mRNA medicines. His expertise in RNA purification has positioned him as a key player in the biotechnology sector.

Collaborations

Erik collaborates with talented individuals such as Joseph Parella and Kimberly Gillis, contributing to a dynamic and innovative work environment.

Conclusion

Erik Held's contributions to the field of RNA purification exemplify the impact of innovative thinking in biotechnology. His patents and work at Translate Bio, Inc. highlight the importance of advancements in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…